Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Liabilities (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Total Liabilities for 15 consecutive years, with $64.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities rose 32.3% year-over-year to $64.9 million, compared with a TTM value of $64.9 million through Sep 2025, up 32.3%, and an annual FY2024 reading of $49.2 million, up 67.95% over the prior year.
  • Total Liabilities was $64.9 million for Q3 2025 at Sanara MedTech, up from $63.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $64.9 million in Q3 2025 and bottomed at $3.5 million in Q1 2021.
  • Average Total Liabilities over 5 years is $27.0 million, with a median of $19.3 million recorded in 2022.
  • The sharpest move saw Total Liabilities decreased 7.81% in 2021, then surged 273.54% in 2022.
  • Year by year, Total Liabilities stood at $6.2 million in 2021, then surged by 209.32% to $19.3 million in 2022, then skyrocketed by 51.61% to $29.3 million in 2023, then skyrocketed by 67.95% to $49.2 million in 2024, then surged by 32.06% to $64.9 million in 2025.
  • Business Quant data shows Total Liabilities for SMTI at $64.9 million in Q3 2025, $63.4 million in Q2 2025, and $59.7 million in Q1 2025.